Vaccine Development and Clinical Trials

Determining that a vaccine will be a safe and effective response to an infectious disease starts with laboratory testing of a scientific concept. It then moves to animal and human testing. This session will explore the development and clinical trial processes, using examples of the COVID-19 vaccines to improve understanding.

  1. Development
  2. Clinical Trials

Michael L. Gruver, Senior Corporate Counsel, Pfizer, Inc.
Jonathan Walland, Senior Corporate Counsel, Pfizer, Inc.

This session was recorded as part of FDLI’s Virtual Fundamentals of Vaccine Regulation Course in February 2021. 



Get Access

  • +$100 for nonmembers

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content